Home World News Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Prolongs OS Among Patients... World News Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Prolongs OS Among Patients with Early-Stage TNBC By Ogkologos - November 8, 2024 746 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KEYNOTE-522 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR In Memory of Hernán Cortés-Funes: Former ESMO President and Pioneer in... March 10, 2026 First-Line Treatment with Ribociclib plus Letrozole Shows a Significant Overall Survival... March 22, 2022 How Early Cancer Detection and Diagnosis Saved My Life Twice: A... December 27, 2023 Reunión anual de la American Society of Clinical Oncology de 2022:... June 7, 2022 Load more HOT NEWS Glucose Control Key in Reducing Cancer Risk for People with Type... FDA Approves Bosutinib for Paediatric Patients with Chronic Myelogenous Leukaemia Managing Side Effects with South Asian Foods Breast Cancer Patient Takes Silly Pictures During Each Radiation Treatment to...
